Skip to main content
Orum Therapeutics, Inc. logo

Orum Therapeutics, Inc. — Investor Relations & Filings

Ticker · 475830 ISIN · KR7475830006 KO Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-03-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 475830

About Orum Therapeutics, Inc.

https://www.orumrx.com/

Orum Therapeutics is a clinical-stage biotechnology company that develops targeted protein degradation (TPD) therapeutics. The company's proprietary TPD²® platform creates a novel class of antibody-drug conjugates (ADCs), referred to as degrader-antibody conjugates (DACs). This technology combines the cell-targeting precision of antibodies with the catalytic action of protein degraders. The approach is designed to selectively deliver payloads to diseased cells to eliminate intracellular proteins that are difficult to target with conventional drugs. Orum's primary focus is on developing treatments for cancer, aiming to improve efficacy and safety over existing therapies.

Recent filings

Filing Released Lang Actions
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, special relationships, and investment fund structures. Since it is a specific regulatory disclosure regarding shareholding thresholds and ownership changes, it falls under the 'Major Shareholding Notification' category.
2025-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the share ownership, special relationships, and changes in holdings for Orum Therapeutics. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details the shareholding status, changes in ownership, and lists special related parties (shareholders). This corresponds to the 'Major Shareholding Notification' category.
2025-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details the shareholding status of major shareholders and special related parties. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is a broader category for threshold crossings), and given it is a formal regulatory disclosure of ownership structure, it is classified as a Regulatory Filing (RNS).
2025-02-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. This falls under the category of 'Major Shareholding Notification' (MRQ) as it details the ownership status and changes in shareholding for a major shareholder (InterVest Co., Ltd.) in the issuer (Oryx Therapeutics).
2025-02-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This type of filing is specifically used for reporting insider holdings and transactions by directors and major shareholders. In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports detailing share ownership and transactions by company directors and executives.
2025-02-21 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.